BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 28
• 29
• 30

• Drug Development

  Ligand Pharmaceuticals Inc. Announces Positive Preclinical Data on IRAK4 Program at the 2011 American College of Rheumatology Annual Scientific Meeting

  November 7, 2011

   · 

  1 min read
• Pharm Country

  Regeneron Pharmaceuticals, Inc. Announces Presentation at the 2011 Credit Suisse Annual Healthcare Conference

  November 7, 2011

   · 

  1 min read
• Business

  Kinetic Concepts, Inc. Gives Notice of Make-Whole Fundamental Change to Holders of Its 3.25% Convertible Senior Notes Due 2015

  November 7, 2011

   · 

  1 min read
• Pharm Country

  Octapharma USA, Inc. Release: First Clinical Study Comparing Pharmacokinetic Profiles of VWF/FVIII Products Published in Medical Journal

  November 7, 2011

   · 

  4 min read
• Business

  Luna Innovations Inc. Announces Third Quarter Financial Release Date of November 14, 2011

  November 7, 2011

   · 

  1 min read
• Drug Development

  Positive Interim Results from Interferon-Free Phase 2b SOUND-C2 Study with Boehringer Ingelheim Pharmaceuticals, Inc.'s Two Investigational HCV Direct Acting Antivirals Presented at Boehringer Ingelheim Pharmaceuticals, Inc.

  November 7, 2011

   · 

  6 min read
• Drug Development

  Regado Biosciences Presents Positive Efficacy and Safety Substudy Data from the Phase 2b RADAR Trial for the REG1 Anticoagulation System at the Transcatheter Cardiovascular Therapeutics (TCT) Symposium 2011

  November 7, 2011

   · 

  4 min read
• Pharm Country

  Cantel Medical to Present at the Stephens Inc. Fall Investment Conference

  November 7, 2011

   · 

  1 min read
• Genetown

  Insulet Corporation to Present at Upcoming Investor Conferences

  November 7, 2011

   · 

  1 min read
• Biotech Bay

  Interim Data for Merck & Co., Inc.'s VICTRELISTM (boceprevir) in Prior Null Responder Patients with Chronic Hepatitis C Genotype 1 to be Presented at The American Association for the Study of Liver Diseases 2011 Annual Meeting

  November 7, 2011

   · 

  1 min read